EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Characterization of Novel 1,3,4‐Thiadiazole‐Benzo[ b ]Oxepine Derivatives: Study of Their Antiproliferative Activity, Docking, DFT, and ADME–T Properties

Sathish Nallagonda, Ramu Rondla, Sudha Muppavarapu, Venkata Ramana Singamaneni, Avanthi Reddy Basireddy, Kishore Pilli Veera Venkata Nanda, Sunder Pal, Tejeswara Rao Allaka iD

Chemistry & Biodiversity · 2026-03 · 23 (3)

DOI: 10.1002/cbdv.202503136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 10.03.2026. Verfasst von Sathish Nallagonda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Division, Aragen Life Sciences Pvt. Ltd, IDA Mallapur, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Thiadiazoles, Antineoplastic Agents, Molecular Docking Simulation, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Driven by the urgent need for novel anticancer agents capable of overcoming limitations associated with conventional therapies, a new series of benzo[ b ]oxepine derivatives featuring 1,3,4‐thiadiazole ( 5a−5k ) linkers was successfully produced through a Vilsmeier‐Haack reaction, thiazole formation, and C─N cross coupling or an Ullmann‐type coupling reaction with the corresponding hydrazides. The structure of the synthesized compounds was confirmed through various spectroscopic techniques, such as NMR ( 1 H/ 13 C) and HRMS. The cytotoxic activity of the newly synthesized congeners was investigated against MCF‐7, MDA‐MB‐231, and T‐47D (human breast cancer), A549, and PC‐9 (lung cancer) cell lines. It is worth noting that the half maximal inhibitory concentration (IC 50 ) value of 5i against MDA‐MB‐231 cells was 3.50 ± 1.03 µg mL −1 , which was obviously superior to that of etoposide (4.03 ± 1.10 µg mL −1 ). From the screening results, thiadiazole analogues 5a–5k showed excellent inhibitory activity against lung carcinoma in the range of IC 50 values 4.79 ± 1.14 to 40.86 ± 0.93 µg mL −1 . In this series, analogues 5a , 5i , and 5j show a remarkable antiproliferative profile on the T‐47D cell line with IC 50 values of 5.70 ± 0.90, 4.25 ± 0.76, and 4.12 ± 1.35 µg mL −1 by using etoposide as a standard, whose IC 50 is 5.65 ± 0.35 µg mL −1 . Moreover, molecules 5f , 5i , and 5j demonstrated the highest docking scores of −8.83, −8.93, and −9.20 kcal mol −1 in in silico tests conducted on the most potent compounds. These therefore displayed the most hydrophobic, electrostatic, and hydrogen bonding with the estrogen receptor complex in breast cancer (PDB: 5T1Z) because of their highest docking score. Extending our exploration, an analysis of the ADME‐Tox profiling confirmed the safe use of these newly synthesized scaffolds, paving the way for promising therapeutic applications in the field of anticancer therapy. Additionally, DFT analysis identified electron‐rich and electron‐deficient areas on molecules, which were utilized in docking studies to compare polar and non‐polar interactions with kinase. Collectively, these findings underscore the potential of 1,3,4‐thiadiazole hybrids, particularly compounds 5i and 5j , as promising leads for the development of new anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiadiazolesAntineoplastic AgentsMolecular Docking SimulationDrug DesignDensity Functional TheoryHumansCell ProliferationDrug Screening Assays, AntitumorStructure-Activity RelationshipCell Line, TumorMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

1,3,4‐thiadiazoleDFT studyProTox IIantiproliferative activitybenzo[b]oxepinein silico docking

Substanzen

ThiadiazolesAntineoplastic Agents1,3,4-thiadiazole

Autor:innen und Institutionen

  • Medicinal Chemistry Division, Aragen Life Sciences Pvt. Ltd, IDA Mallapur, Hyderabad, Telangana, India.
  • Department of Chemistry, NIILM University, Kaithal, Haryana, India.
  • Department of Chemistry, Nalla Narasimha Reddy Education Society's Group of Institutions, Hyderabad, Telangana, India.
  • Cambrex corporation, Research and Development Center, Charles City, Iowa, USA.
  • Department of Chemistry, Malla Reddy College of Engineering & Technology, Maisammaguda, Secunderabad, Telangana, India.
  • Dr. LARA Centre for Energy Materials, Vignan's Foundation for Science Technology and Research, Guntur, Andhra Pradesh, India.

ORCID-Profile: Tejeswara Rao Allaka

Zitieren

APA

Nallagonda, S., Rondla, R., Muppavarapu, S., Singamaneni, V. R., Basireddy, A. R., Pilli Veera Venkata Nanda, K., Pal, S., & Allaka, T. R. (2026). Design, Synthesis, and Characterization of Novel 1,3,4‐Thiadiazole‐Benzo[ b ]Oxepine Derivatives: Study of Their Antiproliferative Activity, Docking, DFT, and ADME–T Properties. Chemistry & Biodiversity, 23(3). https://doi.org/10.1002/cbdv.202503136

Vancouver

Nallagonda S, Rondla R, Muppavarapu S, Singamaneni VR, Basireddy AR, Pilli Veera Venkata Nanda K, et al. Design, Synthesis, and Characterization of Novel 1,3,4‐Thiadiazole‐Benzo[ b ]Oxepine Derivatives: Study of Their Antiproliferative Activity, Docking, DFT, and ADME–T Properties. Chemistry & Biodiversity. 2026;23(3). doi:10.1002/cbdv.202503136

BibTeX
@article{Nallagonda2026,
  author = {Nallagonda, Sathish and Rondla, Ramu and Muppavarapu, Sudha and Singamaneni, Venkata Ramana and Basireddy, Avanthi Reddy and Pilli Veera Venkata Nanda, Kishore and Pal, Sunder and Allaka, Tejeswara Rao},
  title = {Design, Synthesis, and Characterization of Novel 1,3,4‐Thiadiazole‐Benzo[ b ]Oxepine Derivatives: Study of Their Antiproliferative Activity, Docking, DFT, and ADME–T Properties},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {3},
  doi = {10.1002/cbdv.202503136}
}
Kostenlos starten →